ClinConnect ClinConnect Logo
Search / Trial NCT06194812

Minimal Clinical Important Change of the Turkish Versions of the FABQ TKS, and PCS in Patients With Chronic Neck Pain

Launched by ACIBADEM UNIVERSITY · Dec 22, 2023

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how certain questionnaires can help understand the beliefs and feelings of patients with chronic neck pain. Specifically, the researchers want to see how reliable and sensitive the Turkish versions of the Fear-Avoidance Beliefs Questionnaire, Tampa Kinesiophobia Scale, and Pain Catastrophizing Scale are for people experiencing non-specific neck pain. They aim to find out the smallest change in scores on these questionnaires that would be meaningful for patients and useful in both clinical practice and research.

To be eligible for this trial, participants need to be between 18 and 65 years old and have been diagnosed with chronic neck pain lasting over 12 weeks without a specific cause. They should also be able to communicate well in Turkish and be willing to participate by signing a consent form. However, individuals with certain health conditions, like systemic diseases or recent major health events, or those who have received specific treatments for their neck pain in the past, will not be included. Participants in the study can expect to contribute to important research that could help improve understanding and treatment of chronic neck pain in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:A definitive diagnosis of chronic nonspecific neck pain (documented history of neck pain lasting more than twelve weeks without a recognizable, specific pathoanatomical cause of the pain)
  • Good Turkish communication skills
  • Both genders must be between the ages of 18 and 65,
  • Agreeing to participate in the research and signing the voluntary consent form
  • Exclusion Criteria:
  • Systemic disease, cognitive impairment (Mini Mental State Examination \<24),
  • Recent (\<12 weeks) myocardial infarction, cerebrovascular accident
  • Rheumatoid arthritis, neurological disorders, radiculopathy, infection, tumor, osteoporosis, vertebral fracture, trauma and surgery in the cervical region.
  • Having previously received any exercise therapy and/or pain neuroscience training.
  • Refusal of treatment or failure to comply with treatment (

About Acibadem University

Acibadem University is a leading academic institution in Turkey, dedicated to advancing medical education, research, and healthcare innovation. With a focus on interdisciplinary collaboration, the university conducts cutting-edge clinical trials that aim to enhance patient outcomes and contribute to the global body of medical knowledge. Leveraging state-of-the-art facilities and a robust network of healthcare professionals, Acibadem University fosters an environment of excellence in clinical research, ensuring adherence to the highest ethical standards and regulatory compliance. Through its commitment to scientific discovery and education, the university plays a pivotal role in shaping the future of healthcare both nationally and internationally.

Locations

Istanbul, , Turkey

Patients applied

0 patients applied

Trial Officials

Nuray Alaca, assoc.prof.

Study Chair

Acibadem University

Elif Esma Safran, PhD

Study Chair

Acibadem University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported